ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32 | -11.1% | 15,807 | 0.0% | 0.00% | – |
Q2 2023 | $36 | -14.3% | 15,807 | +15.0% | 0.00% | – |
Q1 2023 | $42 | +13.5% | 13,747 | -12.4% | 0.00% | – |
Q4 2022 | $37 | -99.9% | 15,685 | 0.0% | 0.00% | – |
Q3 2022 | $30,000 | -28.6% | 15,685 | +1.0% | 0.00% | – |
Q2 2022 | $42,000 | +40.0% | 15,537 | +53.9% | 0.00% | – |
Q1 2022 | $30,000 | – | 10,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
Kepos Capital LP | 155,691 | $316 | 0.06% |
Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |